Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen
Open Access
- 1 August 2001
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 28 (3), 243-249
- https://doi.org/10.1038/sj.bmt.1703118
Abstract
We have investigated the immune status of patients with hematologic malignancies treated with a low intensity conditioning in preparation for allogeneic stem cell transplantation. Conditioning consisted of fludarabine, anti-T lymphocyte globulin and low-dose busulfan, followed by infusion of allogeneic blood stem cells. This protocol resulted in rapid engraftment and complete replacement of host with donor hematopoietic cells. Immunological parameters of these patients were compared to those patients who were conditioned by an aggressive myeloablative regimen. Distribution of cell surface markers of lymphocyte subsets from both groups of patients was similar, but different from that of normal control cells. Reduced intensity or non-myeloablative conditioning prior to allogeneic stem cell transplantation (NST), hardly lowered the normal T cell-dependent mitogenic response even during the early period following transplant, while the myeloablative treatments resulted in a suppressed mitogenic reaction and in slow immune recovery. Reactivity of non-MHC restricted cytotoxic T cells was also at a normal level in patients who were treated with NST. We conclude that stem cell engraftment following reduced conditioning may result in early reconstitution of immune responses assessed in vitro. We hypothesize that clinical application of NST may lead to faster development of effective immune responses against residual host-type malignant and abnormal non-malignant hematopoietic cells, although the role of fludarabine on post-transplant infections remains to be investigated in a larger cohort of patients. Bone Marrow Transplantation (2001) 28, 243–249.Keywords
This publication has 37 references indexed in Scilit:
- Management of follicular lymphomaCurrent Opinion in Oncology, 1994
- Expression of p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantationClinical and Experimental Immunology, 1994
- Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-α2a and interleukin-2Cancer Immunology, Immunotherapy, 1992
- Recovery of Natural Cytotoxicity After Bone Marrow TransplantationImmunological Investigations, 1991
- IgG subclass levels and immune reconstitution after T cell-depleted allogeneic bone marrow transplantationClinical and Experimental Immunology, 1990
- Bone Marrow Transplantation in Patients with ThalassemiaNew England Journal of Medicine, 1990
- Immune reconstitution after bone-marrow transplantationCancer Treatment Reviews, 1989
- Total lymphoid irradiationImmunology Today, 1987
- TRANSPLANTATION TOLERANCE ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS AFTER TOTAL LYMPHOID IRRADIATIONTransplantation, 1979
- Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts.The Journal of Experimental Medicine, 1978